<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>Full Initiative — Iowa Family Integrity & Patient Protection Initiative</title>
  <meta name="description" content="Official full text and accessible summary of the Iowa Family Integrity & Patient Protection Initiative, including legislative findings, impairment standards, and implementation strategy." />
  <link rel="canonical" href="https://ginalyncox.github.io/iowa-family-integrity/Full_Initiative.html" />
  <meta property="og:title" content="Full Initiative — Iowa Family Integrity & Patient Protection Initiative" />
  <meta property="og:description" content="Impairment, not presence. A comprehensive policy framework for Iowa's medical-cannabis patient protections." />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="https://ginalyncox.github.io/iowa-family-integrity/Full_Initiative.html" />
  <meta property="og:image" content="assets/favicon.png" />
  <meta name="twitter:card" content="summary" />
  <link rel="icon" type="image/png" href="assets/favicon.png" />
  <link rel="stylesheet" href="style.css" />
</head>

<body>
  <header class="site-header">
    <div class="container">
      <div class="brand">
        <div class="logo" aria-hidden="true">IA</div>
        <h1>Iowa Family Integrity & Patient Protection Initiative</h1>
      </div>
      <nav id="site-nav" aria-label="Primary"></nav>
    </div>
  </header>

  <main id="content" class="container stack">
    <section class="hero section" aria-labelledby="fi-title">
      <span class="pill">Iowa-wide • Legislative + HHS + Judicial</span>
      <h1 id="fi-title">Full Initiative</h1>
      <p>The official, citable version is the PDF below. This HTML mirrors the full text for accessibility and public reference.</p>
      <div class="btn-row" role="group" aria-label="Primary actions">
        <a class="btn primary" href="assets/Full_Initiative.pdf">Download Official PDF</a>
        <a class="btn ghost" href="assets/Policy_Packet.pdf">Policy Packet (PDF)</a>
        <a class="btn ghost" href="assets/Legislative_Draft.pdf">Legislative Draft (PDF)</a>
      </div>
    </section>

    <section class="card section" aria-labelledby="pdf-embed">
      <h2 id="pdf-embed">Official PDF (Embedded View)</h2>
      <object data="assets/Full_Initiative.pdf#view=FitH" type="application/pdf" width="100%" height="800" aria-label="Full Initiative PDF">
        <iframe src="assets/Full_Initiative.pdf#view=FitH" width="100%" height="800" title="Full Initiative PDF"></iframe>
      </object>
    </section>

    <section class="card section" aria-labelledby="summary">
      <h2 id="summary">Executive Summary</h2>
      <dl class="facts">
        <div class="fact"><dt>Core Standard</dt><dd><strong>Impairment—not presence</strong>—governs safety determinations in child-welfare contexts.</dd></div>
        <div class="fact"><dt>Patient Status</dt><dd>Lawful participation under the <cite>Iowa Medical Cannabidiol Act (Iowa Code § 124E)</cite> may not be treated as neglect, abuse, or unfitness <em>per se</em>.</dd></div>
        <div class="fact"><dt>Scope</dt><dd>Legislative clarification • Iowa HHS interpretive guidance (<cite>Iowa Code § 17A.7</cite>) • Judicial education • Perinatal safeguards.</dd></div>
      </dl>
    </section>

    <section class="card section" aria-labelledby="toc">
      <h2 id="toc">Table of Contents</h2>
      <ul class="ul-clean">
        <li><a href="#preamble">1. Preamble & Findings</a></li>
        <li><a href="#definitions">2. Definitions</a></li>
        <li><a href="#impairment-standard">3. Impairment Standard</a></li>
        <li><a href="#prohibited">4. Prohibited Practices</a></li>
        <li><a href="#perinatal">5. Perinatal & Postnatal Safeguards</a></li>
        <li><a href="#hhs-guidance">6. Iowa HHS Guidance (§ 17A.7)</a></li>
        <li><a href="#judicial">7. Judicial Education & Bench Memo</a></li>
        <li><a href="#implementation">8. Implementation & Effective Date</a></li>
        <li><a href="#severability">9. Severability</a></li>
        <li><a href="#contact">10. Contact</a></li>
        <li><a href="#background">11. Background & Rationale</a></li>
        <li><a href="#implementation-pathway">12. Implementation Pathway & Coalition Strategy</a></li>
      </ul>
    </section>

    <!-- 1–10 legislative sections -->
    <section id="preamble" class="card section">
      <h2>1. Preamble & Findings</h2>
      <p>Iowa affirms that patients lawfully participating in the state’s medical-cannabis program, as established under the <cite>Iowa Medical Cannabidiol Act (Iowa Code § 124E)</cite>, may do so under licensed clinical supervision. Family integrity is a compelling state interest. Policy must distinguish responsible medical treatment from actual endangerment.</p>
      <p>This Initiative clarifies standards so that child-welfare assessments and judicial determinations reflect evidence-based evaluations of <em>impairment</em>, not metabolite detection windows. It complements administrative procedures under <cite>Iowa Code § 17A.7</cite>, ensuring Iowa HHS guidance aligns with statute and current medical understanding.</p>
    </section>

    <section id="definitions" class="card section">
      <h2>2. Definitions</h2>
      <p><strong>(A)</strong> “Lawful patient” — An individual registered or otherwise authorized under <cite>Iowa Code § 124E</cite>, including designated caregivers.</p>
      <p><strong>(B)</strong> “Presence” — Detection of cannabinoids or metabolites without accompanying evidence of functional impairment.</p>
      <p><strong>(C)</strong> “Impairment” — Observable, articulable diminution in a caregiver’s capacity to provide safe care (e.g., attention, coordination, judgment) temporally related to use.</p>
      <p><strong>(D)</strong> “Child-welfare proceeding” — Intake, assessment, removal, safety planning, adjudication, disposition, review, and permanency hearings conducted under Iowa law.</p>
    </section>

    <section id="impairment-standard" class="card section">
      <h2>3. Impairment Standard</h2>
      <p><strong>(A)</strong> Lawful patient status and metabolite presence shall not, standing alone, constitute neglect, abuse, or unfitness.</p>
      <p><strong>(B)</strong> Safety determinations must rely on objective evidence of impairment: contemporaneous observations, performance indicators, collateral information, and toxicology interpreted relative to functional impact.</p>
      <p><strong>(C)</strong> When considering toxicology, weigh specimen type, detection window, cutoff thresholds, timing, and correlation to observed behavior.</p>
    </section>

    <section id="prohibited" class="card section">
      <h2>4. Prohibited Practices</h2>
      <ul class="ul-clean">
        <li>Per se findings based solely on lawful patient status or metabolite presence.</li>
        <li>Safety plans, removals, or supervised visitation orders grounded solely in toxicology absent impairment evidence.</li>
        <li>Disparate treatment of medical-cannabis patients relative to other prescribed medications absent impairment evidence.</li>
      </ul>
    </section>

    <section id="perinatal" class="card section">
      <h2>5. Perinatal & Postnatal Safeguards</h2>
      <p>Perinatal/postnatal screening and reporting shall be guided by impairment and objective safety risk. Positive toxicology alone—maternal or neonatal—shall not be treated as neglect, abuse, or unfitness absent corroborating evidence of impairment or harm.</p>
      <p>Care coordination should prioritize informed consent, lactation/pediatric guidance, and non-punitive supports.</p>
    </section>

    <section id="hhs-guidance" class="card section">
      <h2>6. Iowa HHS Guidance (<cite>Iowa Code § 17A.7</cite>)</h2>
      <p><strong>(A)</strong> Iowa HHS shall issue interpretive guidance applying the Impairment Standard to intake, assessment, and case management, including:</p>
      <ul class="ul-clean">
        <li>Documentation of observable impairment indicators;</li>
        <li>Appropriate use/limits of toxicology in family assessments;</li>
        <li>Sample case-note language and safety-plan templates;</li>
        <li>Training and quality-assurance review for statewide consistency.</li>
      </ul>
      <p><strong>(B)</strong> Guidance is reviewed periodically and updated to reflect current science and Iowa law.</p>
    </section>

    <section id="judicial" class="card section">
      <h2>7. Judicial Education & Bench Memo</h2>
      <p>The Judicial Branch should circulate a concise bench memo summarizing the Impairment Standard, evidentiary considerations, and appropriate weighting of toxicology. Detection windows complicate inferences about recent use and functional impact; <strong>impairment—not presence—controls</strong>.</p>
    </section>

    <section id="implementation" class="card section">
      <h2>8. Implementation & Effective Date</h2>
      <p><strong>(A)</strong> Legislative provisions take effect on the first day of the second month following enactment.</p>
      <p><strong>(B)</strong> Iowa HHS publishes interpretive guidance within 120 days and initiates training within 180 days.</p>
      <p><strong>(C)</strong> Existing policies conform on the next regular update cycle after the effective date.</p>
    </section>

    <section id="severability" class="card section">
      <h2>9. Severability</h2>
      <p>If any provision or application is held invalid, the remainder and other applications are not affected.</p>
    </section>

    <section id="contact" class="card section">
      <h2>10. Contact</h2>
      <p>Interviews, data requests, or draft language review:</p>
      <ul class="ul-clean">
        <li><strong>Press:</strong> gina.lyn.cox@gmail.com</li>
        <li><strong>Founder:</strong> Gina Lyn Cox</li>
      </ul>
      <p><small>Version &amp; Citation: Iowa Family Integrity &amp; Patient Protection Initiative — Draft 2025. Prepared by Gina Lyn Cox (Altoona, IA).</small></p>
    </section>

    <section id="background" class="card section">
      <h2>11. Background & Rationale</h2>
      <p>Iowa’s medical-cannabis framework, codified under <cite>Iowa Code § 124E</cite>, allows patients to access lawful therapeutic products under physician supervision. Yet, across family and juvenile courts, lawful patients have faced inconsistent treatment—sometimes penalized solely for the presence of metabolites unrelated to impairment.</p>
      <p>This inconsistency has produced unequal protection and unnecessary removals, especially in perinatal and chronic-pain contexts. Clarifying that <strong>impairment—not presence—</strong>is the controlling standard restores alignment between medical evidence, patient rights, and Iowa’s long-standing family-integrity values.</p>
      <blockquote cite="https://www.legis.iowa.gov/docs/code/124E.pdf">
        “The state has a duty to protect children from harm and a duty to protect the integrity of lawful medical treatment.”
      </blockquote>
      <p>Clarifying these protections will reduce caseworker uncertainty, prevent due-process violations, and conserve resources by focusing attention where genuine risk exists.</p>
    </section>

    <section id="implementation-pathway" class="card section">
      <h2>12. Implementation Pathway & Coalition Strategy</h2>
      <p>The Initiative invites broad collaboration to ensure smooth adoption and effective application statewide. This includes legislative sponsorship, administrative coordination, and community engagement. Each stakeholder has a defined role:</p>
      <ul class="ul-clean">
        <li><strong>Iowa Legislature:</strong> Introduce and refine model language through Health & Human Services and Judiciary committees.</li>
        <li><strong>Iowa HHS:</strong> Draft and issue interpretive guidance under <cite>Iowa Code § 17A.7</cite> with expert consultation.</li>
        <li><strong>Judicial Branch:</strong> Circulate a bench memorandum clarifying evidentiary weighting and procedural fairness.</li>
        <li><strong>Advocacy & Medical Organizations:</strong> Provide testimony, clinical context, and educational outreach.</li>
        <li><strong>Community Stakeholders:</strong> Identify affected families, collect data, and support equitable access to lawful care.</li>
      </ul>
      <p>This initiative is intentionally nonpartisan and data-driven, reflecting Iowa’s values of family integrity, medical autonomy, and procedural fairness.</p>
      <p>Future updates may include educational resources, continuing legal-education modules, and interagency coordination frameworks.</p>
      <p><strong>Next Steps:</strong> Contact <a href="mailto:gina.lyn.cox@gmail.com">gina.lyn.cox@gmail.com</a> to request the editable bill draft and implementation template.</p>
    </section>
  </main>

  <footer class="site-footer">
    <div class="container">
      <p>&copy; <span id="yr"></span> Iowa Family Integrity & Patient Protection Initiative.</p>
    </div>
  </footer>

  <script src="script.js" defer></script>
</body>
</html>
